Status:
ENROLLING_BY_INVITATION
RCT to Test Regional Anesthesia Effect on Decreased Opiate Use
Lead Sponsor:
United States Naval Medical Center, Portsmouth
Conditions:
Postoperative Pain
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Examining use of strong pain medication with the use of perioperative anesthetic medications vs no use of the same perioperative medication
Detailed Description
Control group: 1. At the end of the Septorhinoplasty while the patient is still under general anesthesia, an associate investigator assisting in the case will administer normal saline to V2 (maxillar...
Eligibility Criteria
Inclusion
- Patients receiving a primary septorhinplasty at NMCP or Langley Air Force Base
Exclusion
- History of alcohol abuse/dependence, mental health medications or opiate use disorder. Revision surgery
Key Trial Info
Start Date :
December 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2026
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06989866
Start Date
December 1 2024
End Date
September 1 2026
Last Update
October 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Naval Medical Center Portsmouth
Portsmouth, Virginia, United States, 23708